Home Cart 0 Sign in  
X

[ CAS No. 292170-96-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 292170-96-8
Chemical Structure| 292170-96-8
Chemical Structure| 292170-96-8
Structure of 292170-96-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 292170-96-8 ]

Related Doc. of [ 292170-96-8 ]

Alternatived Products of [ 292170-96-8 ]

Product Details of [ 292170-96-8 ]

CAS No. :292170-96-8 MDL No. :MFCD01788370
Formula : C8H9BrN2O Boiling Point : -
Linear Structure Formula :- InChI Key :NHTSTHBGCFFUMF-UHFFFAOYSA-N
M.W : 229.07 Pubchem ID :23437049
Synonyms :

Calculated chemistry of [ 292170-96-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.83
TPSA : 33.2 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.99 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.98
Log Po/w (XLOGP3) : 1.0
Log Po/w (WLOGP) : 1.55
Log Po/w (MLOGP) : 0.99
Log Po/w (SILICOS-IT) : 1.43
Consensus Log Po/w : 1.39

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.13
Solubility : 1.7 mg/ml ; 0.00744 mol/l
Class : Soluble
Log S (Ali) : -1.29
Solubility : 11.9 mg/ml ; 0.0517 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.94
Solubility : 0.261 mg/ml ; 0.00114 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.54

Safety of [ 292170-96-8 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 292170-96-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 292170-96-8 ]

[ 292170-96-8 ] Synthesis Path-Downstream   1~6

  • 1
  • [ 292170-96-8 ]
  • 5-mercapto-N,N-dimethyl-3-pyridinecarboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium thiomethoxide; In DMF (N,N-dimethyl-formamide); at 100℃; for 4h; Sodium thiomethoxide (3g) was added to a stirred solution of 5-bromo-N, N-DIMETHYL-3- pyridinecarboxamide (2. 5g, W02000055168) in NN-DIMETHYLFORMAMIDE (40ML) and the suspension stirred at 100C for 4h. The solvent was concentrated in vacuo, the residue dissolved in 2M sodium hydroxide (35ML) and water (50ml), and the solution washed with chloroform (4 x 75ML). The aqueous layer was acidified with 2M hydrochloric acid to pH 4 and extracted with chloroform (5 x 80MOI), and the combined organic layers were washed with brine (20ml), dried over magnesium sulphate and concentrated in vacuo to give the title compound as an orange oil (1. 8g). LC/MS Rt 0. 96min, M/Z 183 [MH+]
  • 2
  • [ 39620-02-5 ]
  • [ 124-40-3 ]
  • [ 292170-96-8 ]
YieldReaction ConditionsOperation in experiment
89% With pyridine; In tetrahydrofuran; at 20℃; for 6h; Preparation of intermediate: 5-Bromo-N,N-dimethyl-nicotinamide: Into a 100 mL round bottomed flask were added 5-bromonicotinoyl chloride (0.531 g, 2.41 mmol) and anhydrous pyridine (5 mL). A 2M solution of dimethylamine in THF (5 mL, 10.0 mmol) was added dropwise, and the reaction mixture was stirred at rt under N2 for 6 h after which it was concentrated under vacuum. The crude residue was partitioned between EtOAc and water. The layers were separated, and the organic phase was washed 3* with water, then treated with brine, dried (Na2SO4), filtered and concentrated to afford 5-Bromo-N,N-dimethyl-nicotinamide as a brown oil (0.4951 g, 89%). MS: m/z 229/231 [MH+].
89% With pyridine; In tetrahydrofuran; at 20℃; for 6h; Into a 100 mL round bottomed flask were added 5-bromonicotinoyl chloride (0.53 Ig, 2.41 mmol) and anhydrous pyridine (5 mL). A 2M solution of dimethylamine in THF (5mL, 10.0 mmol) was added dropwise, and the reaction <n="54"/>mixture was stirred at rt under N2 for 6 h after which it was concentrated under vacuum. The crude residue was partitioned between EtOAc and water. The layers were separated, and the organic phase was washed 3X with water, then treated with brine, dried (Na2SO4), filtered and concentrated to afford 5-Bromo-lambdazetaN- dimethyl-nicotinamide as a brown oil (0.495 Ig, 89%). MS: m/z 229/231 [MH+].
  • 3
  • [ 292170-96-8 ]
  • [ 875639-17-1 ]
  • 5-[3-(2-Methoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethyl-nicotinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
57% Step 1: Synthesis of 5-[3-(2-Methoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethyl-nicotinamide. Into a 5 mL Personal Chemistry microwave reaction vial were added 3-(2-Methoxy-phenyl)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine (0.136 g, 0.270 mmol), <strong>[292170-96-8]5-Bromo-N,N-dimethyl-nicotinamide</strong> (0.0756 g, 0.332 mmol; preparation described below), 1,1'-bis(diphenylphosphino)ferrocenepalladium(II)-dichloride dichloromethane adduct (16.2 mg, 0.01 mmol), acetonitrile (2 mL) and saturated aqueous NaHCO3 (2 mL). The vial was sealed, purged with N2, and irradiated in a Personal Chemistry Optimizer at 90 C. for 15 min. The layers were separated, and the aqueous phase was extracted 3* with EtOAc. The combined organic phase was treated with brine, dried (Na2SO4), filtered and concentrated. The crude product was dissolved in 3:1 MeOH/acetone (4 mL total) and treated with 500 muL of 50% w/w KOH(aq) for 1 h. Glacial Acetic acid was added to obtain pH 7, then the reaction mixture was concentrated. The residue was partitioned between EtOAc and water, then the layers were separated, and the organic phase was washed 2* with water. The organic phase was treated with brine, dried (Na2SO4), filtered and concentrated. Purification by flash silica gel chromatography using a gradient of ethyl acetate (containing 10% MeOH) and hexanes afforded the title compound as a tan powder (57 mg, 57%). 1H-NMR (500 MHz, d6-DMSO) delta=11.96 (br. s, 1H), 8.95 (d, J=2.5 Hz, 1H), 8.56(d, J=2.0 Hz, 1H), 8.52 (d, J=2.0 Hz, 1H), 8.24(d, J=2.0 Hz, 1H), 8.13(t, J=2.0 Hz, 1H), 7.72(d, J=3.0 Hz, 1H), 7.59(dd, J=2.0, 5.5 Hz, 1H), 7.25 (dd, J=1, 7.5 Hz,1H), 7.08(d, J=7.5 Hz, 1H), 6.99(t, J=7.5 Hz, 1H), 3.76(s, 3H), 2.97 (s, 3H), 2.92(s, 3H); MS: m/z 373.1 [MH+].
  • 4
  • [ 292170-96-8 ]
  • [ 875639-17-1 ]
  • C29H26N4O4S [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium hydrogencarbonate;dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; In water; acetonitrile; at 90℃; for 0.25h;Microwave irradiation; Into a 5 mL Personal Chemistry microwave reaction vial were added 3-(2-Methoxy-phenyl)-5- (4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine (0.136 g, 0.270 mmol), 5-Bromo-NN-dimethyl-nicotinamide (0.0756 g, 0.332 mmol; preparation described below), l,r-bis(diphenylphosphino)ferrocene-rhoalladium(?)-dichloride dichloromethane adduct (16.2 mg, 0.01 mmol), acetonitrile (2 mL) and saturated aqueous NaHCO3 (2 mL). The vial was sealed, purged with N2, and irradiated in a Personal Chemistry Optimizer at 90 C for 15 min. The layers were separated, and the aqueous phase was extracted 3X with EtOAc. The combined organic phase was treated with brine, dried (Na2SO4), filtered and concentrated. The crude product was dissolved in 3:1 MeOH/acetone (4 mL total) and treated with 500 muL of 50% w/w KOH(aq) for 1 h. Glacial Acetic acid was added to obtain pH 7, then the reaction mixture was concentrated. The residue was partitioned between EtOAc and water, then the layers were separated, and the organic phase was washed 2X with water. The organic phase was treated with brine, dried (Na2SO4), filtered and concentrated. Purification by flash silica gel chromatography using a gradient of ethyl acetate (containing 10% MeOH) and hexanes afforded the title compound as a tan powder (57 mg, 57%). 1H-NMR (500 MHz, ^6-DMSO) delta= 11.96 (br. s, 1H), 8.95 (d, J=2.5 Hz, 1H), 8.56(d, J=2.0 Hz, 1H), 8.52 (d, J=2.0 Hz, 1H), 8.24(d, J=2.0 Hz, 1H), 8.13(t, J=2.0 Hz, 1H), 7.72(d, J=3.0 Hz, 1H), 7.59(dd, J=2.0, 5.5 Hz, 1H), 7. 25 (dd, J=I, 7.5 Hz,1H), 7.08(d, J=7.5 Hz, 1H), 6.99(t, J=7.5 Hz, 1H), 3.76(s, 3H), 2.97 (s, 3H), 2.92(s, 3H); MS: m/z 373.1 [MH+].
  • 6
  • [ 153435-68-8 ]
  • [ 74-88-4 ]
  • [ 292170-96-8 ]
YieldReaction ConditionsOperation in experiment
42 mg Sodium hydride (60% in oil) (28 mg) was added to a DMF (2.4 ml) solution containing 5-bromo-N-methylnicotinamide (100 mg), followed by stirring at 45C for 1 hour. Methyl iodide (43 mul) was added under ice cooling, followed by stirring at room temperature for 1 hour. A saturated aqueous ammonium chloride solution and ethyl acetate were added to the reaction mixture. The organic layer was collected, washed with saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled away under reduced pressure. Hexane was added to the obtained residue, solid matter was collected by filtration, and a white solid of 5-bromo-N,N-dimethylnicotinamide (42 mg) was thus obtained. 1H-NMR (DMSO-d6, 400MHz) delta:8.78 (d, 1H, J = 2.2Hz), 8.61 (d, 1H, J = 1.8Hz), 8.14 (dd, 1H, J = 1.9, 2.2Hz), 3.00 (s, 3H), 2.92 (s, 3H) MS (ESI, m/z): 229, 231 (M+H)
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 292170-96-8 ]

Bromides

Chemical Structure| 104290-44-0

[ 104290-44-0 ]

5-Bromo-N,N-diethylnicotinamide

Similarity: 0.97

Chemical Structure| 153435-68-8

[ 153435-68-8 ]

5-Bromo-N-methylnicotinamide

Similarity: 0.95

Chemical Structure| 303031-43-8

[ 303031-43-8 ]

N-Benzyl-5-bromonicotinamide

Similarity: 0.93

Chemical Structure| 342013-83-6

[ 342013-83-6 ]

(5-Bromopyridin-3-yl)(4-methylpiperazin-1-yl)methanone

Similarity: 0.92

Chemical Structure| 1017782-91-0

[ 1017782-91-0 ]

(5-Bromopyridin-3-yl)(piperazin-1-yl)methanone

Similarity: 0.92

Amides

Chemical Structure| 104290-44-0

[ 104290-44-0 ]

5-Bromo-N,N-diethylnicotinamide

Similarity: 0.97

Chemical Structure| 153435-68-8

[ 153435-68-8 ]

5-Bromo-N-methylnicotinamide

Similarity: 0.95

Chemical Structure| 303031-43-8

[ 303031-43-8 ]

N-Benzyl-5-bromonicotinamide

Similarity: 0.93

Chemical Structure| 342013-83-6

[ 342013-83-6 ]

(5-Bromopyridin-3-yl)(4-methylpiperazin-1-yl)methanone

Similarity: 0.92

Chemical Structure| 1017782-91-0

[ 1017782-91-0 ]

(5-Bromopyridin-3-yl)(piperazin-1-yl)methanone

Similarity: 0.92

Amines

Chemical Structure| 104290-44-0

[ 104290-44-0 ]

5-Bromo-N,N-diethylnicotinamide

Similarity: 0.97

Chemical Structure| 153435-68-8

[ 153435-68-8 ]

5-Bromo-N-methylnicotinamide

Similarity: 0.95

Chemical Structure| 303031-43-8

[ 303031-43-8 ]

N-Benzyl-5-bromonicotinamide

Similarity: 0.93

Related Parent Nucleus of
[ 292170-96-8 ]

Pyridines

Chemical Structure| 104290-44-0

[ 104290-44-0 ]

5-Bromo-N,N-diethylnicotinamide

Similarity: 0.97

Chemical Structure| 153435-68-8

[ 153435-68-8 ]

5-Bromo-N-methylnicotinamide

Similarity: 0.95

Chemical Structure| 303031-43-8

[ 303031-43-8 ]

N-Benzyl-5-bromonicotinamide

Similarity: 0.93

Chemical Structure| 342013-83-6

[ 342013-83-6 ]

(5-Bromopyridin-3-yl)(4-methylpiperazin-1-yl)methanone

Similarity: 0.92

Chemical Structure| 1017782-91-0

[ 1017782-91-0 ]

(5-Bromopyridin-3-yl)(piperazin-1-yl)methanone

Similarity: 0.92